InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: Tatsumaki post# 389290

Thursday, 09/22/2022 1:18:18 PM

Thursday, September 22, 2022 1:18:18 PM

Post# of 426487
Since Amarin is said to have collaborated in the Mochida development of MND-2119, would not the royalty on Amarin's; MND-2119 products be set at a reasonable rate which would allow Amarin to sell MND-2119 at a rate as low as or lower than the present price of Vascepa?...Has Amarin divulged the royalty rates?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News